Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Sulfoxanthicillin from the deep-sea derived Penicillium sp. SCSIO sof101: an antimicrobial compound against Gram-positive and -negative pathogens


Natural products along with their analogs have been intensively explored for their antimicrobial potential against ‘ESKAPE’ pathogens. Herein, we report a new natural product with strong antibacterial activity, sulfoxanthocillin (1), along with its decomposed product peniformamide (2), and the known compound xanthocillin X (3) from the deep-sea derived Penicillium sp. SCSIO sof101. The structures of compounds 1 and 2 were determined by extensive spectroscopic analysis. Compound 1 showed significant activity against series pathogens with MIC values ranging 0.06–8.0 μg mL−1. As an artificial unnatural product during the isolation process, compound 2 had lower antimicrobial activity than that of compound 1, which could be attributed to a change in structural modification from an isonitrile group in compound 1 to a formamide group in compound 2. In terms of cytotoxicity, 1 showed relatively low cytotoxicity against human tumor cell lines compared with xanthocillin X (3), suggesting that the sulfate group present in 1 should be a determinant of cytotoxic activities. Overall, sulfoxanthocillin (1) merits further attention as a potential lead compound for anti-infective interventions against Gram-negative and Gram-positive bacterial pathogens.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3
Fig. 4


  1. Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod. 2020;83:770–803.

    Article  CAS  Google Scholar 

  2. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J. Bad bugs, no drugs: no ESKAPE! An update from the infectious diseases society of america. Clin Infect Dis. 2009;48:1–12.

    Article  Google Scholar 

  3. Imai Y, Meyer KJ, Iinishi A, Favre-Godal Q, Green R, Manuse S, Caboni M, Mori M, Niles S, Ghiglieri M, Honrao C, Ma X, Guo JJ, Makriyannis A, Linares-Otoya L, Böhringer N, Wuisan ZG, Kaur H, Wu R, Mateus A, Typas A, Savitski MM, Espinoza JL, O'Rourke A, Nelson KE, Hiller S, Noinaj N, Schäberle TF, D'Onofrio A, Lewis K. A new antibiotic selectively kills Gram-negative pathogens. Nature 2019;576:459–64.

    Article  CAS  Google Scholar 

  4. Lack of new antibiotics threatens global efforts to contain drug-resistant infections. 2020,

  5. Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis. 2017,

  6. Pendleton JN, Gorman SP, Gilmore BF. Clinical relevance of the ESKAPE pathogens. Expert Rev Anti Infect Ther. 2013;11:297–308.

    Article  CAS  Google Scholar 

  7. Rothe W. The new antibiotic xanthocillin. Dtsch Med Wochenschr. 1954;79:1080–1.

    Article  CAS  Google Scholar 

  8. Takatsuki A, Suzuki S, Ando K, Tamura G, Arima K. New antiviral antibiotics; xanthocillin X mono- and dimethylether, and methoxy-xanthocillin X dimethylether. I. Isolation and characterization. (Studies on antiviral and antitumor antibiotics. V). J Antibiot. 1968;21:671–5.

    Article  CAS  Google Scholar 

  9. Yamaguchi T, Miyake Y, Miyamura A, Ishiwata N, Tatsuta K. Structure-activity relationships of xanthocillin derivatives as thrombopoietin receptor agonist. J Antibiot. 2006;59:729–34.

    Article  CAS  Google Scholar 

  10. Tsunakawa M, Ohkusa N, Kobaru S, Narita Y, Murata S, Sawada Y, Oki T. BU-4704, a new member of the xanthocillin class. J Antibiot. 1993;46:687–8.

    Article  CAS  Google Scholar 

  11. Lim FY, Won TH, Raffa N, Baccile JA, Wisecaver J, Rokas A, Schroeder FC, Keller NP. Fungal isocyanide synthases and xanthocillin biosynthesis in Aspergillus fumigatus. Mbio 2018;9:e00785–18.

    Article  CAS  Google Scholar 

  12. Itoh J, Takeuchi Y, Gomi S, Inouye S, Mikawa T, Yoshikawa N, Ohkishi H. MK4588, a new antibiotic related to xanthocillin. J Antibiot. 1990;43:456–61.

    Article  CAS  Google Scholar 

  13. Isaka M, Boonkhao B, Rachtawee P, Auncharoen P. A xanthocillin-like alkaloid from the insect pathogenic fungus Cordyceps brunnearubra BCC 1395. J Nat Prod. 2007;70:656–8.

    Article  CAS  Google Scholar 

  14. Hübner I, Shapiro JA, Hoßmann J, Drechsel J, Hacker SM, Rather PN, Pieper DH, Wuest WM, Sieber SA. Broad spectrum antibiotic xanthocillin X effectively kills Acinetobacter baumannii via dysregulation of heme biosynthesis. ACS Cent Sci. 2021;7:488–98.

    Article  Google Scholar 

  15. West AV, Woo CM. Ironing out new antibiotic mechanisms with Xanthocillin X. ACS Cent Sci. 2021;7:403–5.

    Article  CAS  Google Scholar 

  16. Song Y, Yang J, Yu J, Li J, Yuan J, Wong NK, Ju J. Chlorinated bis-indole alkaloids from deep-sea derived Streptomyces sp. SCSIO 11791 with antibacterial and cytotoxic activities. J Antibiot. 2020;73:542–7.

    Article  CAS  Google Scholar 

  17. Sun C, Liu Z, Zhu X, Fan Z, Huang X, Wu Q, Zheng X, Qin X, Zhang T, Zhang H, Ju J, Ma J. Antitubercular ilamycins from marine-derived Streptomyces atratus SCSIO ZH16 ilaR. J Nat Prod. 2020;83:1646–57.

    Article  CAS  Google Scholar 

  18. Dong Y, Ding W, Sun C, Ji X, Ling C, Zhou Z, Chen Z, Chen X, Ju J. Julichrome monomers from marine gastropod mollusk-associated Streptomyces and stereochemical revision of julichromes Q3-5 and Q3-3. Chem Biodivers. 2020;17:e2000057.

    CAS  Google Scholar 

  19. Luo M, Cui Z, Huang H, Song X, Sun A, Dang Y, Lu L, Ju J. Amino acid conjugated anthraquinones from the marine-derived fungus Penicillium sp. SCSIO sof101. J Nat Prod. 2017;80:1668–73.

    Article  CAS  Google Scholar 

  20. Zuck KM, Shipley S, Newman DJ. Induced production of N-formyl alkaloids from Aspergillus fumigatus by co-culture with Streptomyces peucetius. J Nat Prod. 2011;74:1653–7.

    Article  CAS  Google Scholar 

  21. Song Y, Li Q, Liu X, Chen Y, Zhang Y, Sun A, Zhang W, Zhang J, Ju J. Cyclic hexapeptides from the deep south china sea-derived Streptomyces scopuliridis SCSIO ZJ46 active against pathogenic Gram-positive bacteria. J Nat Prod. 2014;77:1937–41.

    Article  CAS  Google Scholar 

  22. CLSI. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 9th ed. CLSI document M07-A9. Wayne, PA: Clinical and Laboratory Standards Institute; 2012.

  23. Ding B, Yuan J, Huang X, Wen W, Zhu X, Liu Y, Li H, Lu Y, He L, Tan H, She Z. New dimeric members of the phomoxanthone family: phomolactonexanthones A, B and deacetylphomoxanthone C isolated from the fungus Phomopsis sp. Mar Drugs. 2013;11:4961–72.

    Article  CAS  Google Scholar 

Download references


This research was funded by National Natural Science Foundation of China (22077128, 22037006, U2106207), Guangdong Provincial Marine Economic Development (Six Major Marine Undertakings) Special Fund Project (GDNRC[2021]54), Key-Area Research and Development Program of Guangdong Province (2020B1111030005), Key Science and Technology Project of Hainan Province (ZDKJ202018), Major Project of Basic and Applied Basic Research of Guangdong Province (2019B030302004), Local Innovation and Entrepreneurship Team Project of Guangdong (2019BT02Y262) and Open Programe of Shenzhen Bay Laboratory (SZBL2021080601006). We thank the analytical facility center of the South China Sea Institute of Oceanology. In particular, we acknowledge Dr. Zhihui Xiao and Dr. Xiaohong Zheng for recording NMR data, and Ms. Aijun Sun, Ms. Yun Zhang, and Xuan Ma for acquisition of HRESIMS data. Additionally, we acknowledge Professor Chang Chen for his kind gifts of pathogenic bacteria Vibrio sp. strains, Professor Jianhua Liu from South China Agricultural University and Professor Nai-Kei Wong from the third People’s Hospital of Shenzhen for the gifts of other pathogenic bacteria.

Author information

Authors and Affiliations


Corresponding authors

Correspondence to Yongxiang Song or Jianhua Ju.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yang, J., Song, Y., Zhou, Z. et al. Sulfoxanthicillin from the deep-sea derived Penicillium sp. SCSIO sof101: an antimicrobial compound against Gram-positive and -negative pathogens. J Antibiot 76, 113–120 (2023).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


Quick links